Message from the President and CEO
NASDAQ: 2.29
TSX: 2.89
FR
-
EN
About
Our history
Board of Directors
Leadership Team
Scientific Consultants and Advisors
Awards
COVID 19
Commercialized products
Trogarzo®
EGRIFTA®
EGRIFTA SV®
Product Pipeline
Investors
Overview
Investor Presentations
News
Financial Reports and Public Filings
Corporate Governance
Analysts
FAQ
Careers
Contact
Contact information
Email alerts
RSS Feed
Recherche
FR
-
EN
About
Our history
Board of Directors
Leadership Team
Scientific Consultants and Advisors
Awards
COVID 19
Commercialized products
Trogarzo®
EGRIFTA®
EGRIFTA SV®
Product Pipeline
Investors
Overview
Investor Presentations
News
Financial Reports and Public Filings
Corporate Governance
Analysts
FAQ
Careers
Contact
Contact information
Email alerts
RSS Feed
Recherche
FR
-
EN
November 07, 2019
Theratechnologies-sponsored symposium at EACS 2019 entitled “Beating resistance: finding new treatment paths for difficult-to-treat HIV patients”